1.上海中医药大学附属龙华医院泌尿外科(上海 200032)
2.上海市第一人民医院泌尿外科(上海 200080)
3.上海交通大学医学院附属新华医院崇明分院泌尿外科(上海 202150)
4.上海市名中医周智恒泌尿男科工作室(上海 200032)
白慧明,男,硕士研究生,主要从事中医治疗泌尿外科的临床研究工作。
郁超,主任医师,硕士研究生导师;E-mail:yubeyond@163.com
扫 描 看 全 文
白慧明, 谈鸣岳, 孙宾, 等. 上海地区膀胱癌患者中医证型分布及临床特征的多中心研究[J]. 上海中医药杂志, 2021,55(10):14-18.
Huiming BAI, Mingyue TAN, Bin SUN, et al. Multicenter study on distribution of TCM syndrome types and clinical features of bladder cancer patients in Shanghai[J]. Shanghai Journal of Traditional Chinese Medicine, 2021,55(10):14-18.
白慧明, 谈鸣岳, 孙宾, 等. 上海地区膀胱癌患者中医证型分布及临床特征的多中心研究[J]. 上海中医药杂志, 2021,55(10):14-18. DOI: 10.16305/j.1007-1334.2021.2101154.
Huiming BAI, Mingyue TAN, Bin SUN, et al. Multicenter study on distribution of TCM syndrome types and clinical features of bladder cancer patients in Shanghai[J]. Shanghai Journal of Traditional Chinese Medicine, 2021,55(10):14-18. DOI: 10.16305/j.1007-1334.2021.2101154.
目的,2,探讨上海地区膀胱癌患者中医证型分布情况以及临床特征。,方法,2,选择上海地区膀胱癌患者525例,采用中医证候问卷的方法调查中医证型分布情况,同时调查病理结果(是/非浸润性膀胱癌),然后在非浸润性膀胱癌患者中再进一步调查患者的病理细胞分级(高/低危)、膀胱镜检查的相关情况(肿瘤数目:单发/多发)、病史情况(发病年龄;发病情况:首发/复发),采用生活质量问卷评定患者的生存质量。,结果,2,①525例患者中,男性患者占比68.0%,女性患者占比32.0%。中医证型中,瘀毒蕴结型、湿热下注型占比较高,其后依次是肾阴不足型、无证可辨/其他型和脾肾两虚型;病理显示非浸润性膀胱癌和浸润性膀胱癌患者的中医证型分布存在差异(,P,<,0.05)。非浸润性膀胱癌患者占比最多的中医证型为湿热下注型,浸润性膀胱癌患者占比最多为瘀毒蕴结型。②非浸润性膀胱癌患者中,低级别占比最多的中医证型是湿热下注型,高级别是瘀毒蕴结型。③非浸润性膀胱癌主要中医证型中,湿热下注型的排尿症状、肠道症状评分明显高于其他证型(,P,<,0.05),瘀毒蕴结型疼痛症状评分明显高于其他证型(,P,<,0.05)。,结论,2,上海地区膀胱癌的中医证型以湿热下注、瘀毒蕴结两型为主,发病最多的非浸润性膀胱癌患者中亦是呈现此两种证型占比最多。非浸润性膀胱癌与浸润性膀胱癌中医证型分布特征比较有差异,非浸润性膀胱癌患者中瘀毒蕴结型因较其他证型病理级别、浸润性和复发率等方面差异明显,尤需引起临床重视。
Objective,2,To investigate the distribution and clinical features of TCM syndromes in bladder cancer patients in Shanghai.,Methods,2,525 cases of bladder cancer in Shanghai were investigated by TCM syndrome questionnaire, and the pathological results (yes/non-invasive bladder cancer) were investigated. Then the pathological cell grade (high/low risk), cystoscopy (number of tumors: single/multiple), history (age of onset, incidence: initial/recurrence) were investigated in the non-invasive bladder cancer patients and life scale was used to evaluate the quality of life.,Results,2,①Among 525 patients, male patients accounted for 68.0% and female patients accounted for 32.0%. In the patients’ TCM syndrome, the damp-heat perfusion type and stasis toxin accumulation type were relatively high, Then followed by deficiency of kidney yin type, non-documented/other TCM syndrome type and deficiency of spleen and kidney yang; Pathology showed that there was a difference in TCM syndrome distribution between non-invasive bladder cancer and invasive bladder cancer (,P,<,0.05). The highest proportion of TCM syndrome type was damp-heat perfusion type in non-invasive bladder cancer. The most invasive bladder cancer patients was stasis toxin accumulation type. ②The most middle and low grade TCM syndrome in non-invasive bladder cancer patients was damp-heat perfusion type. The high level was stasis toxin accumulation type. ③Among the main TCM syndromes of non-invasive bladder cancer, the scores of urination symptom and intestinal symptom of damp-heat perfusion type were significantly higher than those of other syndromes (,P,<,0.05), and the score of pain symptom of stasis toxin accumulation type was significantly higher than that of other syndromes (,P,<,0.05).,Conclusions,2,The TCM syndromes of bladder cancer in Shanghai are mainly damp-heat perfusion type and stasis toxin accumulation type, among which non-invasive bladder cancer had the most incidence. The distribution of TCM syndromes of non-invasive bladder cancer was different from that of invasive bladder cancer. The non-invasive bladder cancer patients with stasis toxin accumulation type were significantly different from other syndrome types in terms of pathological grade, infiltration and recurrence rate, which should be paid attention in clinical.
膀胱癌非浸润性中医证候流行病学生存质量瘀毒蕴结
bladder cancernon-invasiveTCM syndromesepidemiologyquality of lifestasis toxin accumulation
TAN W S, RODNEY S, LAMB B, et al. Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States,Europe and Asia[J]. Cancer Treat Rev, 2016(47): 22-31.
赵攀,李明东,王昭翔,等. 卡介苗膀胱灌注预防中、高危非肌层浸润性膀胱癌复发的疗效及安全性[J]. 现代泌尿外科杂志,2020, 25(8): 702-707.
黄丽萍,姜慧萍,王大志. 非肌层浸润性膀胱癌灌注治疗技术研究进展[J]. 临床普外科电子杂志,2020, 8(2): 43-46.
关豪. 非肌层浸润性膀胱癌术后药物灌注化疗的疗效分析[D]. 沈阳:中国医科大学,2017.
叶晶琳,周琴,左明焕. 膀胱癌血尿的中西医治疗进展[J]. 现代中医临床,2016, 23(2): 47-49,52.
那彦群,叶章群,孙颖浩,等. 2014版中国泌尿外科疾病诊断治疗指南[M]. 北京:人民卫生出版社,2014: 131-135.
刘猷枋,张亚强. 中西医结合泌尿外科学[M]. 北京:人民军医出版社,2007: 362-366.
孙尚见. 膀胱癌中医临床疗效评价指南[C]//中华中医药学会肿瘤分会. 2012首届全国中医肿瘤高峰论坛论文集. 北京:中华中医药学会肿瘤分会工作组,2012: 196-197.
徐迪华,徐剑秋. 中医量化诊断[M]. 南京:江苏科学技术出版社,1997: 6.
伦雪萍,静进. 浅表性膀胱癌患者应对方式与生存质量相关性研究[J]. 中华肿瘤防治杂志,2013, 20(22): 1763-1766.
曹敬毅,王淇超,孙卫兵,等. 钬激光技术治疗非肌层浸润性膀胱癌的临床疗效分析[J]. 国际泌尿系统杂志,2018, 38(2): 185-187.
李伟亮,陈瑛,颜伟,等. 2-TURBT治疗NMIBC的疗效及对近期复发的影响[J]. 海南医学,2019, 30(17): 2268-2270.
彭颖皓,刘春永,邱华云,等. 膀胱癌患者术后生活质量状况及其影响因素分析[J]. 中国肿瘤临床与康复,2015, 22(1): 98-100.
郁超,曹宏文,陈磊,等. 芪慈三苓汤对非肌层浸润性膀胱癌术后患者复发率影响的临床研究[J]. 上海中医药杂志,2018, 52(7): 43-47.
汪开新,段红英. 浅论用中西医结合疗法预防非肌层浸润性膀胱癌术后复发的临床效果[J]. 当代医药论丛,2017, 15(6): 131-132.
张元芳. 重视对膀胱癌发病机制、诊断和治疗的研究[J]. 上海医学,2003, 26(5): 295-296.
李占鹰,郭晓强,蔡鸿杰,等. 蕴毒理论浅析[J]. 中国民族民间医药,2020, 29(11): 6-9.
0
浏览量
261
下载量
0
CSCD
1
CNKI被引量
关联资源
相关文章
相关作者
相关机构